MMedXYNews
HomeVideos
MedXY AI/MedXY News/Tag: C-reactive protein
MedXY News
EnglishTag

C-reactive protein

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationcritical carebiomarkersartificial intelligencetype 1 diabetesclinical trialsHypertensiononcologyCardiologyMortalitypublic healthcardiovascular diseasediabetesAlzheimer's diseasebreast cancerepidemiology

Latest news

Tag

Early Identification of Low Anastomotic Leakage Risk Using Postoperative Day 2 C-Reactive Protein After Colon Cancer Surgery
General Surgeryanastomotic leakageC-reactive protein

Early Identification of Low Anastomotic Leakage Risk Using Postoperative Day 2 C-Reactive Protein After Colon Cancer Surgery

By MedXY|Oct 15, 2026

Postoperative day 2 C-reactive protein under 100 mg/L effectively excludes anastomotic leakage with high negative predictive value, enabling earlier and safer discharge in colon cancer resection patients within ERAS protocols.

C-Reactive Protein as a Prognostic Biomarker in Infarct-Related Cardiogenic Shock: Insights from the ECLS-SHOCK Trial
Cardiologyacute myocardial infarction
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
C-reactive protein

C-Reactive Protein as a Prognostic Biomarker in Infarct-Related Cardiogenic Shock: Insights from the ECLS-SHOCK Trial

By MedXY|Aug 16, 2025

Elevated CRP levels independently predict short-term mortality in acute myocardial infarction complicated by cardiogenic shock, with extracorporeal life support showing no survival benefit regardless of CRP levels or admission timing.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Cardiology
Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models